ToddDLevineMD

PubMed

• 3 citations
  Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial.
  Pedro M Machado, Michael P McDermott, Thomas Blaettler, Claus Sundgreen, Anthony A Amato, Emma Ciafaloni, Miriam Freimer, Summer B Gibson, Sarah M Jones, Todd D Levine...> ;The Lancet. Neurology. 2023 Oct 1
• Reply to "Intravenous saline may not be a placebo in patients with small fiber neuropathy".
  Christopher H Gibbons, Sharika Rajan, Katherine Senechal, Erin Hendry, Brady McCallister, Todd D Levine> ;Muscle & Nerve. 2023 Jun 1
• 1 citations
  Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.
  Mamatha Pasnoor, Vera Bril, Todd Levine, Jaya Trivedi, Nicholas J Silvestri, Milind Phadnis, Hans D Katzberg, David S Saperstein, Gil I Wolfe, Laura Herbelin, Kiley Hi...> ;European Journal of Neurology. 2023 May 1
• 8 citations
  A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies.
  Christopher H Gibbons, Sharika Rajan, Katherine Senechal, Erin Hendry, Brady McCallister, Todd D Levine> ;Muscle & Nerve. 2023 May 1
• 8 citations
  Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies.
  Christopher H Gibbons, Roy Freeman, Bailey Bellaire, Charles H Adler, Dan Moore, Todd Levine> ;Biomarkers in Medicine. 2022 May 1
• 8 citations
  Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.
  Merit Cudkowicz, Angela Genge, Nicholas J. Maragakis, Susanne Petri, Leonard H. van den Berg, Valtteri V Aho, Toni Sarapohja, Mikko Kuoppamäki, Chris Garratt, Ammar Al...> ;The Lancet. Neurology. 2021 Oct 1
• 1 citations
  X-Linked Dystonia-Parkinsonism (“Lubag”) May Present with Peripheral Synucleinopathy
  Virgilio Gerald H. Evidente, Danica H. Evidente, Susan C. Ortega, Todd Levine, Roy Freeman, ChristopherH. Gibbons> ;Movement Disorders. 2021 Sep 28
• 125 citations
  Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;The Lancet. Neurology. 2021 Jul 1
• 7 citations
  Cutaneous alpha-synuclein deposition in postural tachycardia patients.
  Todd Levine, Bailey Bellaire, Christopher H. Gibbons, Roy Freeman> ;Annals of Clinical and Translational Neurology. 2021 Mar 25
• Correction to: A Global Survey of Disease Burden in Patients Who Carry a Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy
  Jeffrey A. Allen, Lisa Butler, Todd Levine, Anne Haudrich> ;Advances in Therapy. 2021 Feb 1
• 21 citations
  Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Stud...
  Rohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, Mazen M. Dimachkie, Irene Beckmann, Todd Levine> ;Medicine. 2021 Jan 8
• 5 citations
  A Global Survey of Disease Burden in Patients Who Carry a Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy
  Jeffrey A. Allen, Lisa Butler, Todd Levine, Anne Haudrich> ;Advances in Therapy. 2021 Jan 1
• 19 citations
  Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria.
  Roy Freeman, Jennifer S. Gewandter, Catharina G. Faber, Christopher H. Gibbons, Simon Haroutounian, Giuseppe Lauria, Todd Levine, Rayaz A. Malik, J. Robinson Singleton...> ;Neurology. 2020 Dec 1
• 29 citations
  Cryptogenic small-fiber neuropathies: Serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor-3
  Todd Levine, Jafar Kafaie, Lawrence A. Zeidman, David Saperstein, Reyanna Massaquoi, Ruth Bland, Alan Pestronk> ;Muscle & Nerve. 2020 Apr 1
• 6 citations
  Safety of an Abbreviated Transition Period When Switching From Intravenous Immunoglobulin to Eculizumab in Patients with Treatment-Refractory Myasthenia Gravis: A Case...
  Todd D. Levine> ;The American Journal of Case Reports. 2019 Jul 6
• 7 citations
  Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy study
  Todd Levine, Jonathan S. Katz, Richard J. Barohn, Leslie Vaughan, Mazen M. Dimachkie, David Saperstein, Tahseen Mozaffar, Gil I. Wolfe, Matthew S. Mayo, Gary J. Badger...> ;Neurology. Clinical Practice. 2018 Oct 1
• 33 citations
  Small Fiber Neuropathy: Disease Classification Beyond Pain and Burning.
  Todd D Levine> ;Journal of Central Nervous System Disease. 2018 Apr 18
• 23 citations
  Studies of Environmental Risk Factors in Amyotrophic Lateral Sclerosis (ALS) and a Phase I Clinical Trial of L-Serine.
  Walter G. Bradley, R. X. Miller, Todd Levine, Elijah W. Stommel, Paul Alan Cox> ;Neurotoxicity Research. 2018 Jan 1
• 6 citations
  Incidence of nonamyloidogenic mutations in the transthyretin gene in patients with autonomic and small fiber neuropathy.
  Todd Levine, Ruth Bland> ;Muscle & Nerve. 2018 Jan 1
• 9 citations
  Renal and hematologic side effects of long‐term intravenous immunoglobulin therapy in patients with neurologic disorders
  Aidan Levine, Todd Levine, Kathie Clarke, David Saperstein> ;Muscle & Nerve. 2017 Dec 1
• 23 citations
  The Presence of Alpha-Synuclein in Skin from Melanoma and Patients with Parkinson's Disease.
  Ildefonso Rodriguez-Leyva, Erika Chi-Ahumada, Manuel Mejía, Juan Pablo Castanedo-Cazares, William Eng, Sami K. Saikaly, Juan Carrizales, Todd D. Levine, Robert A. Norm...> ;Movement Disorders Clinical Practice. 2017 Jun 1
• 32 citations
  Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid α-Glucosidase in Pompe Patients Co-administered with Alglucosidase α
  , , , , , , , , , , , , , , , , , , , , , , , , , > ;Molecular Therapy. 2017 May 3
• 54 citations
  Phase I clinical trial of safety of L-serine for ALS patients
  Todd Levine, Robert G. Miller, Walter G. Bradley, Dan H. Moore, David Saperstein, Lynne E. Flynn, Jonathan S. Katz, Dallas A. Forshew, James S. Metcalf, Sandra Anne Ba...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2017 Jan 2
• 2 citations
  ALSUntangled 38: L-serine
  Veronica Peschansky, Richard Bedlack, Colin Quinn, Chafic Karam, Alexander Sherman, Lyle Ostrow, Orla Hardiman, Terry Heiman-Patterson, Laurie Gutmann, Mark Bromberg, ...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2017 Jan 2
• 1 citations
  ALSUntangled No. 36: Accilion
  Richard Bedlack, Emma Fixsen, Colin Quinn, Chafic Karam, Alexander Sherman, Lyle Ostrow, Orla Hardiman, Terry Heiman-Patterson, Laurie Gutmann, Mark Bromberg, Gregory ...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2017 Jan 2
• Join now to see all